Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription painkiller,

Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of OxyContin as part of the latest legal settlement stemming from

The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain medication OxyContin accountable for their role in the opioid crisis.

The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was rejected by the Supreme Court.

Everything in my life is shaped by a company that put profits over human lives,” one woman who became addicted to OxyContin said.

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and other states said.

Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler family and their former company, Purdue Pharma, the makers of OxyContin. The Utah Attorney General’s Office and Utah’s Department of Commerce Division of Consumer Protection said they expect to join the settlement in a

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack.